Medical Program: Understanding Treat-to-Target Strategy in the Management of PsA

Understanding Treat-to-Target Strategy in the Management of PsA

Understanding Treat-to-Target Strategy in the Management of PsA
RestartResume
Adopting a treat-to-target approach can significantly improve disease activity in your psoriatic arthritis patients. Have you been hitting the target?
  • Overview

    What matters most to your psoriatic arthritis patients? Knowing the answer plays a big role in any successful treat-to-target strategy, and thanks to these insights from Dr. Elizabeth Volkmann, you can ensure that you’re developing an approach that’s ideal for each individual patient. Dr. Volkmann is a rheumatologist and clinical researcher at the Ronald Reagan Medical Center at UCLA.

    Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

     

Facebook Comments

Sign up for the Rheumatology Academy newsletters.
Comprehensive Rheumatology Education.

Better education for a better you.

* Required
Optional
Rheumatology Updates: Making NORM the Norm
Madelaine A. Feldman, MD, FACR
Register

We’re glad to see you’re enjoying Rheumatology Academy…
but how about a more personalized experience?

Register for free